The question is, will Endo do what the FDA asks? I haven't seen an official word from the company yet. If the withdraw, that opens the door for a lot of lawsuits from overdose deaths, right? On the other hand, if its withdrawn, what company will benefit from those patient moving to another molecule?
The real issue is the power of the fda to even ask. If this does happen, then more opiods to go bye bye. Then the problem is what do all the legitimate pain suffers do? There are more and more real patients everyday going to pain doctors to get help. If they can not prescribe medicatins that will help, the patients only real altenative will be to turn to actual drugs. Is that what our gov't wants?
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm562401.htm So back when ER was reformulated, the FDA stated that it was easier to abuse than the original formula. Frankly, I never understood why they approved it in the first place. I remember seeing this after the reform had been out about 3 months.
